Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dynavax Technologies (DVAX)

Dynavax Technologies (DVAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 813,063
  • Shares Outstanding, K 92,184
  • Annual Sales, $ 35,220 K
  • Annual Income, $ -152,600 K
  • 60-Month Beta 1.12
  • Price/Sales 23.53
  • Price/Cash Flow N/A
  • Price/Book 66.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.14
  • Number of Estimates 2
  • High Estimate -0.12
  • Low Estimate -0.16
  • Prior Year -0.49
  • Growth Rate Est. (year over year) +71.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.08 +9.89%
on 08/07/20
12.44 -37.46%
on 07/20/20
-1.04 (-11.79%)
since 07/07/20
3-Month
3.55 +119.15%
on 05/13/20
12.44 -37.46%
on 07/20/20
+3.24 (+71.37%)
since 05/07/20
52-Week
1.80 +332.22%
on 03/16/20
12.44 -37.46%
on 07/20/20
+4.79 (+160.20%)
since 08/07/19

Most Recent Stories

More News
After Yesterday's Decline of 11.85%, Dynavax Technolo Offers Investors Better Value

Dynavax Technolo (NASDAQ:DVAX) traded in a range yesterday that spanned from a low of $7.08 to a high of $8.23. Yesterday, the shares fell 11.8%, which took the trading range below the 3-day low of $8.52...

DVAX : 7.78 (-11.79%)
Dynavax Technologies (DVAX) Reports Q2 Loss, Misses Revenue Estimates

Dynavax Technologies (DVAX) delivered earnings and revenue surprises of -12.50% and -53.15%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

DVAX : 7.78 (-11.79%)
Dynavax Technologies: 2Q Earnings Snapshot

EMERYVILLE, Calif. (AP) _ Dynavax Technologies Corp. (DVAX) on Thursday reported a loss of $51.6 million in its second quarter.

DVAX : 7.78 (-11.79%)
Dynavax Announces Second Quarter 2020 Financial Results

-- Multiple new CpG 1018 collaborations established to develop novel adjuvanted vaccine candidates across several indications, including COVID-19

DVAX : 7.78 (-11.79%)
Sierra Oncology Strengthens Management Team to Implement North American Pre-Commercialization Strategy for Momelotinib

Sierra Oncology Strengthens Management Team to Implement North American Pre-Commercialization Strategy for Momelotinib

AIMT : 13.77 (-0.07%)
DVAX : 7.78 (-11.79%)
NVS : 82.91 (-0.60%)
SRRA : 11.80 (+4.38%)
Changing Approach to Testing Could Ease Burden on Healthcare Systems

, /PRNewswire/ -- The pandemic has drastically changed the world's social and economic landscape. Countries have shut down schools and businesses, restricted travel, postponed entertainment and sporting...

TOMDF : 0.0890 (-1.11%)
LLY : 152.93 (+0.03%)
VIR : 52.03 (+3.73%)
DVAX : 7.78 (-11.79%)
BNTX : 77.00 (-0.10%)
Pharma Stocks in Focus on Late-Stage Coronavirus Vaccine Trials

Hopes of a vaccine have once again started rising with a number of companies now entering the final phase of their trials.

SNY : 51.51 (+0.02%)
DVAX : 7.78 (-11.79%)
PFE : 38.45 (+0.47%)
GILD : 69.35 (+0.78%)
MRNA : 74.10 (+0.46%)
LLY : 152.93 (+0.03%)
AMGN : 240.69 (-0.36%)
ADPT : 38.22 (-4.66%)
Thinking about trading options or stock in Nio Inc, iBio Inc, Dynavax Technologies, Apple Inc, or Walt Disney?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NIO, IBIO, DVAX, AAPL, and DIS.

AAPL : 444.45 (-2.45%)
DVAX : 7.78 (-11.79%)
IBIO : 3.80 (-6.40%)
NIO : 13.42 (-3.03%)
DIS : 129.93 (-0.68%)
TriSalus Life Sciences Acquires Dynavax's SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales

-- TriSalus plans to further develop SD-101 as an oncology therapeutic

DVAX : 7.78 (-11.79%)
Dynavax to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, will report second quarter 2020 financial results on Thursday, August...

DVAX : 7.78 (-11.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade DVAX with:

Business Summary

Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development...

See More

Key Turning Points

2nd Resistance Point 8.85
1st Resistance Point 8.31
Last Price 7.78
1st Support Level 7.16
2nd Support Level 6.55

See More

52-Week High 12.44
Fibonacci 61.8% 8.38
Last Price 7.78
Fibonacci 50% 7.12
Fibonacci 38.2% 5.86
52-Week Low 1.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar